Literature DB >> 3261708

Differential susceptibility of fresh Trichomonas vaginalis isolates to complement in menstrual blood and cervical mucus.

P Demes1, A Gombosová, M Valent, A Jánoska, H Fabusová, M Petrenko.   

Abstract

The ability of complement in human menstrual blood and cervical mucus to kill Trichomonas vaginalis was compared with that of complement in serum, and 95 fresh trichomonal isolates obtained from vaginal wash material were evaluated for susceptibility to complement immediately after isolation. Only serum and menstrual blood with haemolytic activity produced total cytolysis of T vaginalis. The cytolytic abilities of these fluids were totally inactivated by treatment with heat or edetic acid (EDTA), which confirms the role of complement in cytolysis. Most cervical mucus samples had no detectable trichomonal cytotoxic properties. The cytotoxic activity in the remaining samples was not due to complement, as it was heat stable. Fresh isolates of T vaginalis and subpopulations of fresh isolates differed in their susceptibility or resistance to complement mediated lysis in serum. Resistance to complement did not remain stable after trichomonads were grown in vitro.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261708      PMCID: PMC1194195          DOI: 10.1136/sti.64.3.176

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  18 in total

1.  Identification of a surface antigen of Trichomonas vaginalis.

Authors:  R J Connelly; B E Torian; H H Stibbs
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

2.  Antibody to Trichomonas vaginalis in human cervicovaginal secretions.

Authors:  K E Su
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

3.  Heterogeneity of Trichomonas vaginalis and discrimination among trichomonal isolates and subpopulations with sera of patients and experimentally infected mice.

Authors:  J F Alderete; L Suprun-Brown; L Kasmala; J Smith; M Spence
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

4.  Geographic variation among isolates of Trichomonas vaginalis: demonstration of antigenic heterogeneity by using monoclonal antibodies and the indirect immunofluorescence technique.

Authors:  J N Krieger; K K Holmes; M R Spence; M F Rein; W M McCormack; M R Tam
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

5.  Specific and common antigens of Trichomonas vaginalis detected by monoclonal antibodies.

Authors:  B E Torian; R J Connelly; R S Stephens; H H Stibbs
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

6.  Activation of the alternative complement pathway by Trichomonas vaginalis.

Authors:  F D Gillin; A Sher
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

7.  Trichomonas vaginalis: alternative pathway activation of complement.

Authors:  T W Holbrook; R J Boackle; J Vesely; B W Parker
Journal:  Trans R Soc Trop Med Hyg       Date:  1982       Impact factor: 2.184

8.  Antigen analysis of several pathogenic strains of Trichomonas vaginalis.

Authors:  J F Alderete
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

9.  Analysis of surface saccharides in Trichomonas vaginalis strains with various pathogenicity levels by fluorescein-conjugated plant lectins.

Authors:  A Wartoń; B M Honigberg
Journal:  Z Parasitenkd       Date:  1983

10.  Trichomonas vaginalis: electrophoretic analysis and heterogeneity among isolates due to high-molecular-weight trichomonad proteins.

Authors:  J F Alderete; G Garza; J Smith; M Spence
Journal:  Exp Parasitol       Date:  1986-04       Impact factor: 2.011

View more
  5 in total

1.  Properties of Trichomonas vaginalis grown under chemostat controlled growth conditions.

Authors:  M W Lehker; J F Alderete
Journal:  Genitourin Med       Date:  1990-06

Review 2.  Clinical and microbiological aspects of Trichomonas vaginalis.

Authors:  D Petrin; K Delgaty; R Bhatt; G Garber
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

3.  The vagina has reducing environment sufficient for activation of Trichomonas vaginalis cysteine proteinases.

Authors:  J F Alderete; D Provenzano
Journal:  Genitourin Med       Date:  1997-08

4.  Mouse endometrial stromal cells and progesterone inhibit the activation and regulate the differentiation and antibody secretion of mouse B cells.

Authors:  Li Zhang; Kai-Kai Chang; Ming-Qing Li; Da-Jin Li; Xiao-Ying Yao
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

Review 5.  Trichomoniasis immunity and the involvement of the purinergic signaling.

Authors:  Camila Braz Menezes; Tiana Tasca
Journal:  Biomed J       Date:  2016-09-21       Impact factor: 4.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.